Privacy
About
Contributors
Contact
The Cerbat Gem
.
Headlines
Markets
M&A
Analysts’ Updates
Earnings
Health & Biotech
Technology
..
Amyris Inc. - Get News & Ratings Daily
Enter your email address below to get the latest news and analysts' ratings for Amyris Inc. with our FREE daily email newsletter:
Recent Market News
Leerink Swann Weighs in on Shire PLC’s Q3 2016 Earnings (SHPG)
Equities Analysts Offer Predictions for Whiting Petroleum Corp.’s Q3 2016 Earnings (WLL)
Wolverine World Wide Inc. to Post Q3 2016 Earnings of $0.49 Per Share, B. Riley Forecasts (WWW)
Q3 2016 EPS Estimates for Robert Half International Inc. (RHI) Decreased by Analyst
XL Group PLC (XL) Forecasted to Post Q3 2016 Earnings of $0.38 Per Share
Brokers Offer Predictions for Ur Energy Inc.’s Q3 2016 Earnings (URG)
Leerink Swann Equities Analysts Lift Earnings Estimates for UnitedHealth Group Inc. (UNH)
Research Analysts Offer Predictions for Pinnacle West Capital Corp.’s Q3 2016 Earnings (PNW)
Q3 2016 EPS Estimates for Universal American Corp. Reduced by Leerink Swann (UAM)
Q3 2016 Earnings Estimate for Time Warner Inc. Issued By Wedbush (TWX)
Copper Mountain Mining Co.. (CUM) to Post Q3 2016 Earnings of $0.00 Per Share, National Bank Financial Forecasts
Stewart Information Services Corp. (STC) to Post Q3 2016 Earnings of $0.95 Per Share, Langen Mcalenn Forecasts
RBC Capital Markets Increases Yahoo Inc. (YHOO) Price Target to $45.00
DA Davidson Analysts Cut Earnings Estimates for Gildan Activewear Inc. (GIL)
Equities Analysts Set Expectations for Hallador Energy Co.’s FY2017 Earnings (HNRG)
FY2017 Earnings Estimate for Jack In The Box Inc. (JACK) Issued By SunTrust Banks
FY2017 EPS Estimates for Pfizer Inc. (PFE) Cut by Jefferies Group
FY2017 EPS Estimates for Southwest Gas Corp. (SWX) Raised by Analyst
MGIC Investment Corp. (MTG) Downgraded by Compass Point
Piper Jaffray Cos. Downgrades Sangamo BioSciences Inc. (SGMO) to Neutral
Amyris Inc. (AMRS) Major Shareholder (Mauritius) Pte Ltd Maxwell Sells 2,300,000 Shares of Stock
October 19th, 2016 - By Jessica Moore - 0 comments
Amyris logoAmyris Inc. (NASDAQ:AMRS) major shareholder (Mauritius) Pte Ltd Maxwell sold 2,300,000 shares of the company’s stock in a transaction dated Monday, October 17th. The stock was sold at an average price of $0.83, for a total transaction of $1,909,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Amyris Inc. (NASDAQ:AMRS) opened at 1.08 on Wednesday. The company’s market cap is $253.82 million. The firm’s 50-day moving average is $0.55 and its 200 day moving average is $0.59. Amyris Inc. has a 1-year low of $0.31 and a 1-year high of $1.85.
Amyris (NASDAQ:AMRS) last released its earnings results on Thursday, August 4th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.06. The business earned $9.60 million during the quarter, compared to analysts’ expectations of $15.23 million. During the same quarter in the previous year, the business earned ($0.47) EPS. The business’s revenue for the quarter was up 23.1% on a year-over-year basis. Analysts predict that Amyris Inc. will post ($0.20) earnings per share for the current fiscal year.
A number of brokerages recently issued reports on AMRS. Zacks Investment Research cut shares of Amyris from a “buy” rating to a “hold” rating in a research note on Monday, September 5th. Singular Research reiterated a “buy” rating and issued a $2.80 price target on shares of Amyris in a research note on Wednesday, September 28th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $2.66.
A number of hedge funds have recently added to or reduced their stakes in the company. Jacobs Levy Equity Management Inc. acquired a new stake in Amyris during the first quarter worth $269,000. Geode Capital Management LLC raised its position in shares of Amyris by 11.6% in the first quarter. Geode Capital Management LLC now owns 298,669 shares of the company’s stock valued at $331,000 after buying an additional 30,958 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Amyris by 22.4% in the second quarter. Vanguard Group Inc. now owns 1,701,779 shares of the company’s stock valued at $766,000 after buying an additional 311,142 shares in the last quarter. Institutional investors and hedge funds own 35.68% of the company’s stock.
About Amyris
Amyris, Inc is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels.
5 Day Chart for NASDAQ:AMRS
Receive News & Stock Ratings for Amyris Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris Inc. and related stocks with our FREE daily email newsletter.